News - Gastro-intestinals

Filter

Current filters:

Gastro-intestinals

Popular Filters

90 to 114 of 187 results

EU Court of Justice dismisses AstraZeneca appeal on patent settlement

07-12-2012

The European Union's highest court, the Court of Justice, yesterday dismissed the appeal of Anglo-Swedish…

AstraZenecaEuropeGastro-intestinalsLegalLosecPatentsPharmaceutical

EU Commission approves Bayer's Eylea for wet AMD and Abbott's Humira for pediatric Crohn's

28-11-2012

There was good news yesterday for Germany's Bayer (BAYN: DE) and US health care major Abbott Laboratories…

Abbott LaboratoriesBayerEuropeEyleaGastro-intestinalsHumiraOphthalmicsPharmaceuticalRegeneronRegulation

Rhythm expands Series B financing to $33 Million, adding Pfizer Ventures as an investor

27-11-2012

Boston, USA-based biotech firm Rhythm Pharmaceuticals says it has raised an additional $8 million to…

BiotechnologyFinancialGastro-intestinalsIpsenPfizerResearchRhythm PharmaceuticalsRM-131

Abbott launches Sucampo's Amitiza in Japan

27-11-2012

US drugmaker Sucampo Pharmaceuticals (Nasdaq: SCMP), and marketing partner health care major Abbott Laboratories…

Abbott LaboratoriesAmitizaAsia-PacificGastro-intestinalsMarkets & MarketingPharmaceuticalSucampo

TxCell raises 12.4 million euros to progress OvaSave

26-11-2012

French biotech firm TxCell SA has raised 12.4 million euros ($16.1 million) in a third financing round.…

BiotechnologyFinancialGastro-intestinalsOvaSaveResearchTxCell

Prescription drug costs: USA versus UK

04-11-2012

In the USA, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who…

Cardio-vascularEuropeGastro-intestinalsGenericsNorth AmericaPharmaceuticalPricing

Researchers bust a gut to improve gastrointestinal disorders market

28-10-2012

Drugs to treat gastrointestinal disorders are due to see a significant price drop, as patents run out…

Gastro-intestinalsGenericsMarkets & MarketingPharmaceutical

AstraZeneca gains rights to sell Ironwood's IBS drug in China

24-10-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has entered into an agreement with the USA's Ironwood…

Asia-PacificAstraZenecaGastro-intestinalsIronwood PharmaceuticalsLicensinglinaclotideMarkets & MarketingNexiumNorth AmericaPharmaceutical

Study finds potential use of ustekinumab for Crohn's disease

18-10-2012

Ustekinumab, an antibody proven to treat the skin condition psoriasis, has now shown positive results…

BiotechnologyGastro-intestinalsJanssenJohnson & JohnsonPharmaceuticalResearchStelara Injectionustekinumab

Unanimous FDA advisory panel backing for NPS Pharma's Gattex

17-10-2012

The US Food and Drug Administration's Gastrointestinal Drugs Advisory Committee yesterday voted unanimously…

Gastro-intestinalsGattexNorth AmericaNPS PharmaceuticalsPharmaceuticalRegulationteduglutide

FDA posts briefing papers for review of NPS Pharma's Gattex for SBS

15-10-2012

The USA Food and Drug Administration has posted briefing materials for the October 16 Gastrointestinal…

Gastro-intestinalsGattexNorth AmericaNPS PharmaceuticalsPharmaceuticalRegulation

Abbott's Humira gets FDA backing for new use

30-09-2012

US health care major Abbott Laboratories (NYSE: ABT) says that the US Food and Drug Administration has…

Abbott LaboratoriesGastro-intestinalsHumiraNorth AmericaPharmaceuticalRegulation

Uptake of biosimilars will see Remicade and Humira sales decline in 2017

26-09-2012

The TNF-alpha inhibitors infliximab (Janssen Biotech/Merck/Mitsubishi Tanabe's Remicade) and adalimumab…

BiotechnologyGastro-intestinalsGenericsGlobalHumiraMarkets & MarketingRemicade

EMA backs Almirall's Constella; Bayer's Eylea recommended by CHMP

24-09-2012

The European Medicines Agency last Friday issued a batch of recommendations relating to marketing authorization…

AlmirallBayerConstellaEuropeEyleaGastro-intestinalsIronwood PharmaceuticalsNorth AmericaOphthalmicsPharmaceuticalRegeneronRegulation

Pharmaceutical majors unite in Japan to combat H. pylori

18-09-2012

On August 31, nine pharmaceutical companies operating in Japan (Kyowa Hakko Kirin, Takeda Pharmaceutical,…

Antibiotics and Infectious diseasesAsia-PacificAstraZenecaGastro-intestinalsPharmaceuticalRegulationTakeda Pharmaceuticals

Pfizer links with SFJ Pharma for dacomitinib trial; settles with Mylan

10-09-2012

SFJ Pharmaceuticals Group, a global drug development group of companies which provides a unique co-development…

dacomitinibDetrol LAGastro-intestinalsGenericsLegalMylan LaboratoriesNorth AmericaOncologyPatentsPfizerPharmaceuticalResearchSFJ Pharmaceuticals

Almirall gains rights for IBS drug linaclotide in Mexico

10-09-2012

Spain's largest drugmaker Almirall (ALM. MC) says it has reached an agreement with USA-based Forest Laboratories…

AlmirallForest LaboratoriesGastro-intestinalsLicensinglinaclotidePharmaceuticalSouth America

US gastroenterologists' attitudes to prescribing for Crohn's disease and ulcerative colitis

09-09-2012

When evaluating the most important attributes for emerging therapies for Crohn's disease (CD) and ulcerative…

BiotechnologyGastro-intestinalsHumiraMarkets & MarketingNorth AmericaRemicadeSimponi Injectionvedolizumab

FDA action on Salix' crofelemer delayed until 2013

05-09-2012

There was disappointing news for Salix Pharmaceuticals (Nasdaq: SLXP) with the Food and Drug Administration…

crofelemerGastro-intestinalsNorth AmericaPharmaceuticalRegulationSalix Pharmaceuticals

Takeda's Revestive gets EU clearance for short bowel syndrome

05-09-2012

Japan's largest drugmaker Takeda Pharmaceutical (TSE: 4502) and partner NPS Pharmaceuticals (Nasdaq:…

EuropeGastro-intestinalsNPS PharmaceuticalsPharmaceuticalRegulationRevestiveTakeda Pharmaceuticals

90 to 114 of 187 results

Back to top